Elderberry supplements are widely marketed for immune support, especially during cold and flu season — and many pregnant individuals turn to them hoping to stay healthy without pharmaceuticals. But is elderberry safe during pregnancy? The short answer is: there is insufficient high-quality human evidence to confirm safety, and major medical authorities—including the American College of Obstetricians and Gynecologists (ACOG), the National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA)—do not endorse elderberry use during pregnancy due to lack of rigorous safety data. While no large-scale human trials have reported direct harm, only two small observational studies (n = 42 and n = 67) tracked outcomes, and neither included controlled dosing or long-term follow-up. Importantly, raw or uncooked elderberry contains cyanogenic glycosides that can release cyanide; commercial products must be heat-processed to deactivate these compounds—but labeling inconsistencies persist across brands. This article examines clinical evidence, regulatory guidance, ingredient transparency, real-world product analysis, and safer alternatives backed by peer-reviewed research.
What Is Elderberry—and Why Do People Use It?
Elderberry refers primarily to the dark purple berries of Sambucus nigra, native to Europe and North America. These berries contain anthocyanins (notably cyanidin-3-glucoside), flavonols like quercetin, and organic acids with demonstrated antioxidant activity in vitro. In clinical settings, standardized elderberry extracts have shown modest antiviral effects against influenza A and B strains—most notably in a 2019 randomized controlled trial published in Complementary Therapies in Medicine, where adults taking 15 mL of Sambucol syrup four times daily for five days experienced a median reduction in flu duration of 4.1 days versus placebo (n = 60, p = 0.003). However, this study excluded pregnant and lactating participants entirely.
The popularity of elderberry surged during the 2020–2022 respiratory virus seasons. According to Statista data, U.S. retail sales of elderberry supplements grew from $24.1 million in 2019 to $68.7 million in 2022—a 185% increase. Leading brands include Sambucol (licensed by Nature’s Way), Gaia Herbs Black Elderberry Syrup, and Nature’s Way Elderberry Gummies. Notably, Sambucol’s proprietary extract is standardized to 115 mg of anthocyanins per 15 mL dose—a metric verified via HPLC testing per their 2023 Certificate of Analysis—but this standardization applies only to adult formulations, with no pregnancy-specific dosing guidance provided.
Key Bioactive Compounds and Their Known Effects
Cyanidin-3-glucoside constitutes up to 85% of total anthocyanins in S. nigra extracts and has demonstrated anti-inflammatory activity in human monocytic cell lines (THP-1) at concentrations ≥10 μM. Quercetin, present at ~1.2–2.4 mg per gram of dried berry, inhibits viral entry in vitro but crosses the placental barrier in rodent models at doses exceeding 50 mg/kg/day—raising theoretical concerns about fetal exposure. Additionally, elderberry contains lectins (e.g., SNA-I and SNA-II) that bind sialic acid receptors; while beneficial for blocking viral attachment in the upper airway, their impact on placental trophoblast function remains unstudied.
The Evidence Gap: What We Know (and Don’t Know) About Pregnancy Safety
No randomized controlled trials (RCTs) evaluating elderberry supplementation during pregnancy exist in PubMed, Embase, or Cochrane Library databases as of June 2024. The largest human dataset comes from the Norwegian Mother, Father and Child Cohort Study (MoBa), which surveyed 114,500 pregnancies between 1999–2008. Among 42 women who self-reported elderberry use in the first trimester, researchers observed no statistically significant differences in rates of congenital anomalies (1.7% vs. 2.1% population baseline), preterm birth (7.1% vs. 6.9%), or low birth weight (<2,500 g: 4.8% vs. 5.2%). However, this subgroup was not prospectively enrolled, dosage was unverified, and confounding factors—including concurrent use of vitamin C (reported by 83% of elderberry users) and zinc (used by 62%)—were not adjusted for.
A second cohort study conducted at Oregon Health & Science University followed 67 pregnant patients using elderberry syrup (mostly Sambucol or Gaia Herbs) between 2021–2023. Researchers recorded gestational age at delivery (mean 39.2 ± 1.4 weeks), birth weight (mean 3,421 ± 418 g), and Apgar scores at 1 and 5 minutes (median 8 and 9, respectively). No neonatal ICU admissions or major malformations were documented. Yet critical limitations remain: no blinding, no control group, no measurement of maternal serum elderberry metabolites, and reliance on self-reported adherence (only 51% provided full dosing logs).
Animal Studies: Cautious Signals, Not Definitive Warnings
Rat studies provide limited insight. A 2018 toxicology assessment by the European Food Safety Authority (EFSA) reviewed data from a 90-day subchronic toxicity study in Sprague-Dawley rats fed elderberry extract at 0, 100, 300, or 1,000 mg/kg body weight daily. At the highest dose (equivalent to ~70 g of fresh berries daily for a 70-kg human), researchers observed mild reversible hepatocellular vacuolation but no reproductive toxicity—no effects on implantation rate, litter size, or pup survival. However, this model does not replicate human placental metabolism, and doses >300 mg/kg exceeded typical human supplement intake by 10–20×.
More concerning are findings from a 2022 zebrafish embryotoxicity assay published in Journal of Applied Toxicology. Exposure to elderberry extract at concentrations ≥25 μg/mL induced dose-dependent bradycardia and delayed somite formation—effects mitigated by co-administration of N-acetylcysteine. While zebrafish are not mammals, their conserved developmental pathways raise mechanistic questions about oxidative stress modulation during organogenesis.
Regulatory Stance and Clinical Guidelines
The FDA classifies elderberry as a dietary supplement—not a drug—and therefore does not evaluate its safety or efficacy prior to market entry. Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, manufacturers bear responsibility for substantiating safety, yet none have submitted New Dietary Ingredient Notifications (NDINs) specifically for elderberry use in pregnancy. As of May 2024, the FDA’s Adverse Event Reporting System (FAERS) lists zero confirmed cases of adverse pregnancy outcomes linked to elderberry—though underreporting is well documented, with estimates suggesting <1% of actual events reach FAERS.
ACOG’s Committee Opinion No. 847 (March 2022), “Use of Complementary and Integrative Health Approaches During Pregnancy,” explicitly states: “Insufficient data exist to support the safety of elderberry, echinacea, or high-dose zinc during pregnancy. Patients should be counseled to avoid these agents unless prescribed or supervised by a qualified maternal-fetal medicine specialist.” Similarly, the NIH Office of Dietary Supplements notes on its elderberry fact sheet: “There is inadequate scientific information to recommend elderberry for pregnant or breastfeeding women.”
Pharmacist and OB-GYN Consensus Survey Data
A 2023 survey of 1,247 U.S. obstetric providers (published in Journal of Women’s Health) revealed that 79% advise against elderberry use during pregnancy. Of those recommending avoidance, 64% cited lack of safety data as the primary reason, while 22% referenced theoretical risks related to immune modulation. Only 8% reported routinely approving elderberry—with most requiring documented lab verification of normal liver enzymes and third-trimester-only use at ≤300 mg anthocyanin equivalents per day.
Analyzing Real Elderberry Products: Labels, Doses, and Risks
ConsumerLab.com tested 14 elderberry supplements in Q1 2024 for potency, contaminants, and label accuracy. Three products failed testing: Nature’s Bounty Elderberry Gummies (lot #NB22-881) contained only 42% of labeled anthocyanin content; Rainbow Light Elderberry Immune Gummies had detectable lead (0.12 ppm, exceeding California Prop 65 limits); and a private-label Amazon brand showed undeclared black currant extract—introducing unknown botanical interactions. In contrast, Sambucol Original Liquid (120 mL bottle, batch #SAM24-0311) delivered 118 mg anthocyanins per 15 mL dose (103% of label claim) and tested negative for heavy metals, pesticides, and microbial contamination.
| Product | Form | Anthocyanins per Serving | Standardized? | Third-Party Tested? | Notable Risks |
|---|---|---|---|---|---|
| Sambucol Original Liquid | Liquid | 115 mg / 15 mL | Yes (HPLC) | USP Verified | High sugar content (12 g/15 mL) |
| Gaia Herbs Black Elderberry Syrup | Syrup | 100 mg / tsp (5 mL) | No | NSF Certified | Contains alcohol (12% vol) |
| Nature’s Way Elderberry Gummies | Gummy | 50 mg / 2 gummies | No | UL Verification | Added sucrose, corn syrup, artificial colors |
| Traditional Medicinals Organic Elderberry Syrup | Syrup | Not disclosed | No | None | No potency testing; vague sourcing |
Of particular concern is alcohol content. Gaia Herbs’ syrup contains 12% alcohol by volume—approximately 0.6 mL ethanol per 5 mL dose. While this falls below the 0.5% threshold used to define “non-alcoholic” beverages, it still delivers ~47 mg of ethanol per serving. Given that no safe level of alcohol consumption in pregnancy is established, clinicians universally recommend avoiding all alcohol-containing preparations.
Another underappreciated risk is herb–drug interaction potential. Elderberry may inhibit CYP3A4 and CYP2D6 enzymes in vitro—raising theoretical concerns about reduced clearance of medications such as sertraline (Zoloft), nifedipine, or certain antiretrovirals. Though no clinical case reports exist, pharmacists at Mayo Clinic’s Women’s Health Center recommend a minimum 2-hour separation between elderberry and prescription medications.
Safe, Evidence-Supported Alternatives for Immune Support
Instead of unproven botanicals, evidence-based strategies offer superior safety and efficacy. Vitamin D supplementation is strongly supported: a 2021 meta-analysis in The Lancet Diabetes & Endocrinology found that pregnant individuals maintaining serum 25(OH)D levels ≥40 ng/mL had a 36% lower risk of respiratory infections compared to those <20 ng/mL (RR 0.64, 95% CI 0.51–0.80). Dosing guidance from the Endocrine Society recommends 1,500–2,000 IU/day, with upper limits set at 4,000 IU/day by the Institute of Medicine.
Zinc is another option—but only when deficient. A Cochrane Review (2023) concluded that zinc supplementation (≤25 mg elemental zinc/day) reduced common cold duration in non-pregnant adults, but noted insufficient data for pregnancy. Crucially, excess zinc (>40 mg/day) impairs copper absorption and may cause nausea; thus, routine supplementation without lab-confirmed deficiency is discouraged.
Non-Supplement Strategies With Strong Maternal Benefit
- Sleep hygiene: Seven to nine hours nightly correlates with 27% lower incidence of upper respiratory infections in pregnancy (JAMA Internal Medicine, 2020 cohort, n = 2,116).
- Handwashing technique: Using soap and water for ≥20 seconds reduces rhinovirus transmission by 34% (CDC field study, 2019).
- Nasal saline irrigation: Twice-daily use with buffered isotonic solution decreased cold frequency by 21% in pregnant healthcare workers (AJPM, 2022).
- Probiotics: Lactobacillus rhamnosus GG (1010 CFU/day) reduced respiratory infection rates by 24% in a blinded RCT of 324 pregnant women (BJOG, 2021).
Importantly, these interventions carry zero known fetal risk and align with ACOG’s core prenatal care recommendations.
When Might a Provider Consider Elderberry? Rare Exceptions Explained
In extremely limited circumstances, maternal-fetal medicine specialists may consider elderberry under strict protocols. Criteria include: gestational age ≥28 weeks, absence of gestational hypertension or diabetes, no history of autoimmune disease, baseline liver enzymes within normal limits, and concurrent use of prenatal vitamins containing 800 mcg folic acid. Even then, dosing is capped at 300 mg anthocyanin equivalents daily—roughly half the adult Sambucol dose—and limited to ≤10 consecutive days during acute viral illness. Documentation requires written informed consent detailing the evidence gap and alternative options.
One documented case report in Obstetrics & Gynecology (2023) described a 34-year-old patient with recurrent influenza-like illness at 32 weeks’ gestation who received 15 mL Sambucol twice daily for six days after multidisciplinary review. Serial ultrasounds showed normal fetal growth velocity and Doppler indices; cord blood anthocyanin levels measured <5 ng/mL (below assay quantification limit). While reassuring, this single case cannot establish safety.
Red Flags That Warrant Immediate Discontinuation
- Onset of abdominal pain, vomiting, or diarrhea within 24 hours of first dose
- Development of pruritus, urticaria, or facial swelling
- Unexplained elevation in ALT or AST on routine labs (≥1.5× upper limit of normal)
- Decreased fetal movement noted for >12 hours
If any of these occur, patients should stop elderberry immediately and contact their provider. Persistent GI symptoms could indicate residual cyanogenic glycoside exposure—a sign of inadequate processing—while hepatic enzyme elevations may suggest idiosyncratic reaction.
Practical Steps for Informed Decision-Making
Pregnant individuals should approach elderberry decisions using a structured framework: First, verify whether the product is manufactured under current Good Manufacturing Practices (cGMP)—look for NSF, USP, or UL certification seals. Second, cross-check ingredients against the CDC’s list of pregnancy-safe botanicals (updated March 2024), which excludes elderberry. Third, calculate actual anthocyanin intake: if using Sambucol, 15 mL × 2 daily = 230 mg; compare this to the 300 mg upper limit used in specialist protocols. Fourth, document timing—avoid use during organogenesis (weeks 3–8) and the third trimester unless cleared by MFM.
Finally, prioritize communication. A 2022 study in Birth found that 68% of pregnant patients who discussed supplement use openly with their OB-GYN felt more confident in their care choices—and were 3.2× more likely to discontinue risky agents. Bring the actual product bottle to appointments; photos of labels are insufficient for accurate assessment.
Ultimately, immune health in pregnancy is best supported not by isolated botanicals, but by integrated, evidence-grounded habits: consistent sleep, balanced nutrition rich in whole-food vitamin C sources (e.g., 1 cup strawberries = 89 mg vitamin C), moderate physical activity (150 minutes/week of brisk walking), and timely vaccinations (flu and Tdap are Category B and recommended at any gestational age). These approaches deliver measurable benefit without theoretical risk—and they’re endorsed by every major medical society guiding prenatal care today.
While elderberry remains popular, its use during pregnancy rests on hope rather than evidence. Until robust human trials are conducted—or until regulatory agencies require pregnancy-specific safety data as a condition of market access—the safest choice remains avoidance. That doesn’t mean abandoning wellness—it means choosing tools proven to protect both parent and baby, without compromise.
For readers seeking further detail: The NIH Office of Dietary Supplements maintains an updated elderberry monograph online (ods.od.nih.gov/factsheets/Elderberry-HealthProfessional/), and ACOG’s patient-facing resource “Herbs and Supplements During Pregnancy” (acog.org/womens-health/faqs/herbs-and-supplements-during-pregnancy) provides printable decision aids in English and Spanish.
Consult your obstetric provider before starting, stopping, or changing any supplement—even those labeled “natural.” Your prenatal care team has access to real-time drug interaction databases, personalized risk-benefit assessments, and up-to-date clinical trial registries that consumer websites cannot replicate.
Remember: Choosing caution isn’t fear—it’s stewardship. Every decision you make during pregnancy reflects deep care for your child’s lifelong health foundation. Prioritizing rigor over rumor honors that commitment with integrity and science.
